MCID: FTT003
MIFTS: 47

Fatty Acid Oxidation Disorders malady

Genetic diseases (common) category

Summaries for Fatty Acid Oxidation Disorders

About this section
Sources:
66Wikipedia, 34MalaCards
See all sources

Fully expand this MalaCard

Download this MalaCard
Wikipedia:66 A broad classification for genetic disorders that result from an inability of the body to produce or... more...

MalaCards: Fatty Acid Oxidation Disorders is related to organic acidemia and short-chain acyl-coa dehydrogenase deficiency. An important gene associated with Fatty Acid Oxidation Disorders is CPT2 (carnitine palmitoyltransferase 2), and among its related pathways are beta-Alanine metabolism and Beta oxidation of octanoyl-CoA to hexanoyl-CoA. The compounds Methacrylyl-CoA and Tiglyl-CoA have been mentioned in the context of this disorder. Affiliated tissues include liver, skin and whole blood, and related mouse phenotypes are adipose tissue and muscle.

Aliases & Classifications for Fatty Acid Oxidation Disorders

About this section
Sources:
21GeneTests
See all sources

Classifications:

Malacards categories (disease lists): (See all malacards categories)
Global: Genetic diseases (common)


Aliases & Descriptions:

fatty acid oxidation disorders 21


Related Diseases for Fatty Acid Oxidation Disorders

About this section
Sources:
18GeneCards, 19GeneDecks
See all sources

Diseases related to Fatty Acid Oxidation Disorders via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show all 36)
idRelated DiseaseScoreTop Affiliating Genes
1organic acidemia30.7ACADM, ACADS
2short-chain acyl-coa dehydrogenase deficiency30.4ACADM, ACADS
3d-bifunctional protein deficiency30.4SCP2, HSD17B4
4sudden infant death syndrome30.3HADHA, ACADS, ACADVL, ACADM, SLC25A20
5liver disease10.4
6mitochondrial trifunctional protein deficiency10.4
7trifunctional protein deficiency10.4
83-hydroxyacyl-coa dehydrogenase deficiency10.4
9hellp syndrome10.2
10acute fatty liver of pregnancy10.2
11carnitine-acylcarnitine translocase deficiency10.2
12cyclic vomiting syndrome10.2
13carnitine palmitoyltransferase ii deficiency10.1CPT1A, CPT2
14myoglobinuria recurrent10.1ACADVL, CPT2
15abetalipoproteinemia10.1HADHA, CPT2
16phenylketonuria10.1ACADM, HADHA
17congenital adrenal hyperplasia10.1ACADM, HADHA
18protein s deficiency10.1HADHA, CPT2, SLC25A20
19systemic primary carnitine deficiency disease10.1ACADVL, ACADS, CPT2
20mitochondrial disorders10.0CPT2, SLC25A20
21hypoalphalipoproteinemia10.0PPARA
22rhizomelic chondrodysplasia punctata type 110.0SCP2, HSD17B4
23sudden cardiac death multi-gene panels10.0ACADM, ACADL, ACADVL, HADHA
24rhizomelic chondrodysplasia punctata10.0SCP2, HSD17B4
25galactosemia10.0SLC25A13, ACADVL
26hyperammonemia multi-gene panels10.0SLC25A13, SLC25A20, ACADS
27noonan syndrome10.0HADHA, CPT2, ACADVL, ACADM, SLC25A20
28medium-chain acyl-coenzyme a dehydrogenase deficiency10.0HADHA, ACADS, ACADVL, ACADL, ACADM
29brain disease10.0CPT2, ACADS, ACADM, SLC25A13
30zellweger syndrome10.0SCP2, HSD17B4
31congenital heart disease10.0PPARA, CPT1A, ACADM, SLC25A20
32adrenoleukodystrophy10.0PPARA, HSD17B4, SCP2
33myopathy9.9HADHA, PPARA, CPT1A, CPT2, ACADS, ACADVL
34hypoglycemia9.8SLC25A13, HADHA, SLC25A20, ACADM, ACADL, ACADVL
35metabolic syndrome x9.8HADHA, PPARA, CPT1A, CPT2, ACADS, ACADVL
36fatty liver disease9.8HADHA, PPARA, SCP2, CPT1A, CPT2, ACADVL

Graphical network of the top 20 diseases related to Fatty Acid Oxidation Disorders:



Diseases related to fatty acid oxidation disorders

Symptoms for Fatty Acid Oxidation Disorders

About this section

Drugs & Therapeutics for Fatty Acid Oxidation Disorders

About this section
Sources:
6CenterWatch, 43NIH Clinical Center, 7ClinicalTrials
See all sources

Approved drugs:

Search CenterWatch for Fatty Acid Oxidation Disorders

Drug clinical trials:

Search ClinicalTrials for Fatty Acid Oxidation Disorders

Search NIH Clinical Center for Fatty Acid Oxidation Disorders

Search CenterWatch for Fatty Acid Oxidation Disorders

Genetic Tests for Fatty Acid Oxidation Disorders

About this section
Sources:
21GeneTests
See all sources

Genetic tests related to Fatty Acid Oxidation Disorders:

id Genetic test Affiliating Genes
1 Fatty Acid Oxidation Disorders21
2 Fatty Acid Oxidation Disorders Multi-Gene Panels21

Anatomical Context for Fatty Acid Oxidation Disorders

About this section
Sources:
34MalaCards
See all sources

MalaCards organs/tissues related to Fatty Acid Oxidation Disorders:

34
Liver, Skin, Whole blood, Placenta, Testes

Animal Models for Fatty Acid Oxidation Disorders or affiliated genes

About this section
Sources:
38MGI
See all sources

MGI Mouse Phenotypes related to Fatty Acid Oxidation Disorders:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053758.3ACOT7, ACADVL, SCP2, PPARA
2MP:00053697.9HADHA, PPARA, HSD17B4, ACADS, ACADVL, ACADM
3MP:00107686.7HADHA, PPARA, HSD17B4, CPT1A, ACADS, ACADVL
4MP:00053786.7HADHA, PPARA, HSD17B4, SCP2, ACADVL, ACOT7
5MP:00053706.2SLC25A13, HADHA, PPARA, HSD17B4, SCP2, ACADS
6MP:00053765.7HADHA, PPARA, HSD17B4, SCP2, CPT1A, ACADS

Publications for Fatty Acid Oxidation Disorders

About this section
Sources:
53PubMed
See all sources

Articles related to Fatty Acid Oxidation Disorders:

(show top 50)    (show all 71)
idTitleAuthorsYear
1
Muscle MRI in patients with long-chain fatty acid oxidation disorders. (24305961)
2013
2
Clinical study of organic acidemias and fatty acid oxidation disorders detected in adults. (23524598)
2013
3
Fatty Acid oxidation disorders in a chinese population in taiwan. (23700290)
2013
4
Variability in the clinical management of fatty acid oxidation disorders: results of a survey of Canadian metabolic physicians. (21630065)
2012
5
Acute fatty liver in pregnancy: revealing fetal fatty acid oxidation disorders]. (22325456)
2012
6
Rubratoxin B induces signs of fatty acid oxidation disorders (FAODs) in mice. (21835235)
2011
7
Fatty acid omega-oxidation as a rescue pathway for fatty acid oxidation disorders in humans. (21156023)
2011
8
Current issues regarding treatment of mitochondrial fatty acid oxidation disorders. (20830526)
2010
9
Mitochondrial fatty acid oxidation disorders: pathophysiological studies in mouse models. (20532823)
2010
10
Mitochondrial fatty acid oxidation disorders. Proceedings of an international symposium. October 2008. Fulda, Germany. (21275107)
2010
11
Clinical and biochemical monitoring of patients with fatty acid oxidation disorders. (20066495)
2010
12
Update on mitochondrial fatty acid oxidation disorders. (20842433)
2010
13
Pathophysiology of fatty acid oxidation disorders. (20824345)
2010
14
ESI-MS/MS measurement of free carnitine and its precursor I^-butyrobetaine in plasma and dried blood spots from patients with organic acidurias and fatty acid oxidation disorders. (20637671)
2010
15
Fatty acid oxidation disorders: outcome and long-term prognosis. (20049534)
2010
16
Deuterated palmitate-driven acylcarnitine formation by whole-blood samples for a rapid diagnostic exploration of mitochondrial fatty acid oxidation disorders. (19422814)
2009
17
PPARs as therapeutic targets for correction of inborn mitochondrial fatty acid oxidation disorders. (18392740)
2008
18
3-hydroxyacyl-CoA dehydrogenase (HAD) deficiency replaces short-chain hydroxyacyl-CoA dehydrogenase (SCHAD) deficiency as well as medium- and short-chain hydroxyacyl-CoA dehydrogenase (M/SCHAD) deficiency as the consensus name of this fatty acid oxidation disorder. (17434778)
2007
19
ESI-MS/MS study of acylcarnitine profiles in urine from patients with organic acidemias and fatty acid oxidation disorders. (17301002)
2007
20
Application of tandem mass spectrometry on the diagnosis of fatty acid oxidation disorders]. (18067086)
2007
21
Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts. (16297647)
2006
22
Potential of fibrates in the treatment of fatty acid oxidation disorders: revival of classical drugs? (16763897)
2006
23
Fatty acid oxidation disorder as a cause of sudden infant death syndrome (SIDS)--a case report. (16366103)
2005
24
The association between acute fatty liver of pregnancy and fatty acid oxidation disorders. (15673650)
2005
25
Identification of fatty acid oxidation disorder patients with lowered acyl-CoA thioesterase activity in human skin fibroblasts. (15638818)
2005
26
Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders. (16115821)
2005
27
Human placenta metabolizes fatty acids: implications for fetal fatty acid oxidation disorders and maternal liver diseases. (12582009)
2003
28
Selective screening for fatty acid oxidation disorders by tandem mass spectrometry: difficulties in practical discrimination. (12828998)
2003
29
A method for quantitative acylcarnitine profiling in human skin fibroblasts using unlabelled palmitic acid: diagnosis of fatty acid oxidation disorders and differentiation between biochemical phenotypes of MCAD deficiency. (12385891)
2002
30
Incidence and short-term outcome of children with symptomatic presentation of organic acid and fatty acid oxidation disorders in Germany. (12456920)
2002
31
Management of fatty acid oxidation disorders: a survey of current treatment strategies. (12487544)
2002
32
Prevalent mutations in fatty acid oxidation disorders: diagnostic considerations. (11216903)
2000
33
Acylcarnitines in fibroblasts of patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and other fatty acid oxidation disorders. (10682306)
2000
34
Improving the outcome for fatty acid oxidation disorders. (11045831)
2000
35
Mitochondrial fatty acid oxidation disorders and cyclic vomiting syndrome. (10490047)
1999
36
Sudden and unexpected neonatal death: a protocol for the postmortem diagnosis of fatty acid oxidation disorders. (10331471)
1999
37
A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. (10377439)
1999
38
The use of [9,10-3H]myristate, [9,10-3H]palmitate and [9,10-3H]oleate for the detection and diagnosis of medium and long-chain fatty acid oxidation disorders in intact cultured fibroblasts. (10709659)
1999
39
Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers of 418 cases of sudden death in the first year of life. (9627580)
1998
40
Neonatal onset in fatty acid oxidation disorders: how can we minimize morbidity and mortality? (9762596)
1998
41
Analysis of carnitine esters by radio-high performance liquid chromatography in cultured skin fibroblasts from patients with mitochondrial fatty acid oxidation disorders. (9702916)
1998
42
Dissecting the spectrum of fatty acid oxidation disorders. (9544886)
1998
43
Clinical and biochemical features of fatty acid oxidation disorders. (9848022)
1998
44
Fatty acid oxidation disorders as primary cause of sudden and unexpected death in infants and young children: an investigation performed on cultured fibroblasts from 79 children who died aged between 0-4 years. (9350306)
1997
45
Identification and quantification of intermediates of unsaturated fatty acid metabolism in plasma of patients with fatty acid oxidation disorders. (7586519)
1995
46
Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: a severe fatty acid oxidation disorder. (7813533)
1994
47
Biochemical diagnosis of fatty acid oxidation disorders by metabolite analysis of postmortem liver. (8056418)
1994
48
New developments in the diagnosis and investigation of mitochondrial fatty acid oxidation disorders. (7957387)
1994
49
Fatty acid oxidation disorders: a new class of metabolic diseases. (1625065)
1992
50
Postmortem recognition of fatty acid oxidation disorders. (1866359)
1991

Variations for Fatty Acid Oxidation Disorders

About this section

Expression for genes affiliated with Fatty Acid Oxidation Disorders

About this section
Sources:
2BioGPS, 16Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Fatty Acid Oxidation Disorders

Search GEO for disease gene expression data for Fatty Acid Oxidation Disorders.

Pathways for genes affiliated with Fatty Acid Oxidation Disorders

About this section
Sources:
51PathCards, 31KEGG, 39NCBI BioSystems Database, 56Reactome, 52PharmGKB, 61Thomson Reuters
See all sources

Pathways related to Fatty Acid Oxidation Disorders according to GeneCards/GeneDecks:

(show all 18)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
1
Show member pathways
phenylethylamine degradation I39
9.9ACADM, HADHA
2
Show member pathways
9.9ACADM, HADHA
3
Show member pathways
9.8HADHA, ACADS
4
Show member pathways
oleate biosynthesis II (animals)39
9.7ACOT7, HADHA
59.6CPT1A, ACADVL, ACADM
6
Show member pathways
L-serine degradation39
pentose phosphate pathway (oxidative branch)39
formaldehyde oxidation II (glutathione-dependent)39
9.6ACADM, ACADS, HADHA
79.5HADHA, CPT1A, ACADM
8
Show member pathways
9.5SCP2, HSD17B4
9
Show member pathways
9.5SCP2, HSD17B4
10
Show member pathways
9.5HSD17B4, SCP2
11
Show member pathways
9.3CPT1A, PPARA
12
Show member pathways
fatty acid beta-oxidation I39
eicosapentaenoate biosynthesis II (metazoa)39
gamma-linolenate biosynthesis II (animals)39
fatty acid activation39
9.2SCP2, HSD17B10, HADHA
13
Show member pathways
beta-alanine degradation I39
valine degradation I39
pyruvate fermentation to lactate39
isoleucine degradation I39
9.2HADHA, HSD17B10, ACADS, ACADM
14
Show member pathways
mitochondrial L-carnitine shuttle pathway39
Saturated fatty acid biosynthesis61
8.4HADHA, CPT1A, CPT2, ACADS, ACADVL, ACADL
15
Show member pathways
fatty acid beta-oxidation III (unsaturated, odd number)39
Fatty Acid Beta Oxidation39
7.6ACADS, CPT2, CPT1A, SCP2, HADHA, ACADVL
16
Show member pathways
fatty acid beta-oxidation VI (peroxisome)39
7.5ACADL, CPT2, CPT1A, SCP2, HSD17B4, PPARA
17
Show member pathways
7.3SLC25A20, ACADM, ACADL, ACADVL, ACADS, CPT2
18
Show member pathways
5.3SLC25A13, SLC25A20, ACADM, ACADL, ACADVL, ACADS

Compounds for genes affiliated with Fatty Acid Oxidation Disorders

About this section
Sources:
25HMDB, 46Novoseek, 12DrugBank, 30IUPHAR
See all sources

Compounds related to Fatty Acid Oxidation Disorders according to GeneCards/GeneDecks:

(show top 50)    (show all 224)
idCompoundScoreTop Affiliating Genes
1Methacrylyl-CoA259.7ACADS, HADHA, ACADM
2Tiglyl-CoA259.6ACADS, HADHA, ACADM
3acetyl-l-carnitine469.5HADHA, ACADVL, CPT1A, ACADM
42-methyl-3-hydroxybutyryl-coa46 2510.3HSD17B10, HSD17B4, HADHA
5(3S)-3-Hydroxyadipyl-CoA259.2HSD17B10, HSD17B4, HADHA
6octanoate469.0HADHA, ACADM, CPT1A, PPARA
7s-adenosylmethionine46 25 1210.7CPT1A, CPT2, ACADS, HADHA, SLC25A20, ACADM
8citrate468.5CPT1A, CPT2, HSD17B10, HADHA, PPARA
917beta-hydroxysteroid468.4SCP2, ACADS, HSD17B10, HSD17B4
10linoleic acid30 46 2510.4ACOT7, PPARA, ACADM, CPT1A, CPT2
11pristanic acid46 30 2510.4SLC25A20, ACADL, CPT2, CPT1A, SCP2, PPARA
12oleic acid46 30 25 1211.2ACOT7, CPT1A, SCP2, PPARA, ACADM
13Isobutyryl-CoA258.1ACOT7, ACADL, ACADVL, ACADS, ACADM, HADHA
14Hexanoyl-CoA258.1ACADVL, ACADM, ACOT7, ACADL, PPARA, ACADS
15Glutaconyl-CoA258.1HADHA, PPARA, ACADS, ACADVL, ACADL, ACOT7
16Butyryl-CoA258.1PPARA, ACADVL, ACADL, ACOT7, ACADM, HADHA
172-Methylhexanoyl-CoA258.1HADHA, PPARA, ACADS, ACADVL, ACADL, ACOT7
18Decanoyl-CoA (n-C10:0CoA)258.1ACADM, ACOT7, HADHA, PPARA, ACADS, ACADVL
19Undecanoyl-CoA258.1HADHA, PPARA, ACADS, ACADVL, ACADL, ACOT7
20Tetracosanoyl-CoA258.1PPARA, ACADS, ACADVL, ACADL, ACOT7, HADHA
21Pentanoyl-CoA258.1HADHA, PPARA, ACADS, ACADVL, ACADL, ACOT7
22trans-Octadec-2-enoyl-CoA258.0ACADM, ACOT7, HADHA, PPARA, ACADS, ACADVL
23Lauroyl-CoA258.0ACOT7, ACADM, ACADL, ACADVL, ACADS, HADHA
24Isovaleryl-CoA258.0HADHA, PPARA, ACADS, ACADVL, ACADL, ACOT7
25Nonanoyl-CoA258.0HADHA, PPARA, ACADS, ACADVL, ACADL, ACOT7
262-methylbutyryl-coa46 259.0ACADM, ACADL, ACADVL, PPARA, HADHA, ACOT7
27(2E)-Decenoyl-CoA258.0ACADL, ACOT7, ACADM, ACADVL, HADHA, PPARA
28Eicosanoyl-CoA258.0HADHA, PPARA, ACOT7, ACADL, ACADVL, ACADS
29octanoyl-coa46 259.0ACADVL, HADHA, PPARA, ACADM, ACOT7, ACADL
30(2E)-Dodecenoyl-CoA258.0ACADVL, ACADL, ACOT7, ACADM, HADHA, PPARA
31trans-2-Hexenoyl-CoA258.0PPARA, ACADS, ACADVL, ACADL, ACADM, ACOT7
32Pristanoyl-CoA258.0HADHA, PPARA, ACADS, ACADVL, ACADL, ACADM
33Crotonoyl-CoA258.0HADHA, ACADS, ACADM, ACOT7, ACADVL, ACADL
34(2E)-Octenoyl-CoA258.0ACADVL, ACADS, ACADL, ACOT7, ACADM, HADHA
35palmitate468.0HADHA, PPARA, SCP2, CPT1A, CPT2, ACADVL
363Z-dodecenoyl-CoA258.0PPARA, HADHA, ACADVL, ACADS, ACADL, ACADM
37Acrylyl-CoA258.0ACADM, ACOT7, ACADL, HADHA, ACADS, PPARA
38(2E)-Tetradecenoyl-CoA258.0ACADS, ACADVL, ACADL, ACADM, HADHA, PPARA
39stearoyl-coa46 259.0HADHA, PPARA, ACADS, ACADVL, ACOT7, ACADM
40(2E)-Hexadecenoyl-CoA258.0HADHA, PPARA, ACADS, ACADVL, ACADM, ACOT7
41Propionyl-CoA257.9ACADM, ACOT7, ACADL, ACADS, PPARA, HADHA
42Heptadecanoyl CoA257.9ACADVL, ACADM, HADHA, ACOT7, PPARA, ACADS
43carnitine467.7SLC25A20, ACADM, ACADL, ACADVL, ACADS, CPT2
44glutamate467.5SLC25A13, CPT2, HSD17B10, ACADS, ACADM, PPARA
45Palmityl-CoA257.5PPARA, CPT1A, CPT2, ACADM, ACOT7, ACADS
46Heptanoyl-CoA257.2HADHA, PPARA, ACADM, ACOT7, ACADL, ACADVL
47acetyl-coa46 258.0ACOT7, ACADM, ACADL, CPT2, CPT1A, SCP2
48lipid466.6PPARA, HSD17B10, SCP2, HADHA, ACADL, CPT1A
49acyl-coa465.8SLC25A20, PPARA, HADHA, HSD17B4, HSD17B10, ACADM
50fatty acid465.2HADHA, PPARA, HSD17B4, HSD17B10, SCP2, CPT1A

GO Terms for genes affiliated with Fatty Acid Oxidation Disorders

About this section
Sources:
17Gene Ontology
See all sources

Cellular components related to Fatty Acid Oxidation Disorders according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1mitochondrial nucleoidGO:0426459.9ACADVL, HADHA
2peroxisomal matrixGO:0057829.2SCP2, HSD17B4
3mitochondrial matrixGO:0057598.8HSD17B10, ACADS, ACADVL, ACADL, ACADM
4mitochondrial inner membraneGO:0057438.0HADHA, HSD17B10, CPT1A, CPT2, ACADVL, SLC25A20
5mitochondrionGO:0057395.6SLC25A13, HADHA, HSD17B4, HSD17B10, SCP2, CPT1A

Biological processes related to Fatty Acid Oxidation Disorders according to GeneCards/GeneDecks:

(show all 18)
idNameGO IDScoreTop Affiliating Genes
1carnitine metabolic process, CoA-linkedGO:01925410.2ACADL, ACADM
2negative regulation of fatty acid oxidationGO:04632210.2ACADVL, ACADL
3regulation of cholesterol metabolic processGO:09018110.1ACADVL, ACADL
4negative regulation of fatty acid biosynthetic processGO:04571710.1ACADL, ACADVL
5temperature homeostasisGO:0016599.9ACADVL, ACADL
6carnitine shuttleGO:0068539.9SLC25A20, CPT2, CPT1A
7alpha-linolenic acid metabolic processGO:0361099.7HSD17B4, SCP2
8unsaturated fatty acid metabolic processGO:0335599.6HSD17B4, SCP2
9fatty acid beta-oxidation using acyl-CoA oxidaseGO:0335409.6HSD17B4, SCP2
10fatty acid beta-oxidation using acyl-CoA dehydrogenaseGO:0335399.6ACADS, ACADVL, ACADL, ACADM
11response to starvationGO:0425949.6ACADM, ACADS
12oxidation-reduction processGO:0551149.5ACADM, ACADL, HSD17B4
13positive regulation of fatty acid beta-oxidationGO:0320009.5CPT1A, PPARA
14bile acid metabolic processGO:0082069.5SCP2, HSD17B4
15bile acid biosynthetic processGO:0066999.4SCP2, HSD17B4
16fatty acid beta-oxidationGO:0066358.2ACADM, ACADL, ACADVL, ACADS, CPT2, CPT1A
17cellular lipid metabolic processGO:0442556.6CPT2, CPT1A, SCP2, HSD17B4, PPARA, HADHA
18small molecule metabolic processGO:0442815.6SLC25A13, SLC25A20, ACADM, ACADL, ACADVL, ACADS

Molecular functions related to Fatty Acid Oxidation Disorders according to GeneCards/GeneDecks:

(show all 8)
idNameGO IDScoreTop Affiliating Genes
1long-chain-acyl-CoA dehydrogenase activityGO:0044669.8ACADVL, ACADL
2long-chain-enoyl-CoA hydratase activityGO:0165089.7HADHA, HSD17B4
33-hydroxyacyl-CoA dehydrogenase activityGO:0038579.7HSD17B4, HADHA
4carnitine O-palmitoyltransferase activityGO:0040959.6CPT2, CPT1A
5long-chain fatty acyl-CoA bindingGO:0360429.5ACOT7, SCP2
6acyl-CoA dehydrogenase activityGO:0039959.4ACADS, ACADVL, ACADL, ACADM
7flavin adenine dinucleotide bindingGO:0506609.4ACADS, ACADVL, ACADL, ACADM
8fatty-acyl-CoA bindingGO:0000628.6ACOT7, ACADL, ACADS, SCP2, HADHA

Products for genes affiliated with Fatty Acid Oxidation Disorders

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Fatty Acid Oxidation Disorders

About this section
4CDC
14ExPASy
15FMA
23GTR
24HGMD
25HMDB
26ICD10
27ICD10 via Orphanet
28ICD9CM
30IUPHAR
31KEGG
36MeSH
37MESH via Orphanet
38MGI
41NCIt
42NDF-RT
45NINDS
46Novoseek
48OMIM
49OMIM via Orphanet
53PubMed
54QIAGEN
60SNOMED-CT via Orphanet
63UMLS
64UMLS via Orphanet